TriMaster: randomised double-blind crossover trial of a DPP4-inhibitor, SGLT2-inhibitor and thiazolidinedione to evaluate differential glycaemic response to therapy based on obesity and renal function
TriMaster: randomised double-blind crossover trial of a DPP4-inhibitor, SGLT2-inhibitor and thiazolidinedione to evaluate differential glycaemic response to therapy based on obesity and renal function
复制标题
TriMaster：DPP4 抑制剂、SGLT2 抑制剂和噻唑烷二酮的随机双盲交叉试验，用于评估基于肥胖和肾功能的治疗的差异血糖反应
DOI：
10.21203/rs.3.rs-2132634/v1
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Hattersley A
中科院分区：
文献类型：
--
作者：
Hattersley A
